Copyright Reports & Markets. All rights reserved.

Global Pneumococcal Conjugate Vaccine(PCV) Market Research Report 2020

Request for Sample of this report
Buy now

1 Pneumococcal Conjugate Vaccine(PCV) Market Overview

  • 1.1 Product Overview and Scope of Pneumococcal Conjugate Vaccine(PCV)
  • 1.2 Pneumococcal Conjugate Vaccine(PCV) Segment by Type
    • 1.2.1 Global Pneumococcal Conjugate Vaccine(PCV) Sales Growth Rate Comparison by Type (2021-2026)
    • 1.2.2 Tetravalent Vaccine
    • 1.2.3 8-valent Vaccine
    • 1.2.4 11-valent Vaccine
    • 1.2.5 13-valent Vaccine
  • 1.3 Pneumococcal Conjugate Vaccine(PCV) Segment by Application
    • 1.3.1 Pneumococcal Conjugate Vaccine(PCV) Sales Comparison by Application: 2020 VS 2026
    • 1.3.2 Children
    • 1.3.3 Adult
  • 1.4 Global Pneumococcal Conjugate Vaccine(PCV) Market Size Estimates and Forecasts
    • 1.4.1 Global Pneumococcal Conjugate Vaccine(PCV) Revenue 2015-2026
    • 1.4.2 Global Pneumococcal Conjugate Vaccine(PCV) Sales 2015-2026
    • 1.4.3 Pneumococcal Conjugate Vaccine(PCV) Market Size by Region: 2020 Versus 2026

2 Global Pneumococcal Conjugate Vaccine(PCV) Market Competition by Manufacturers

  • 2.1 Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Manufacturers (2015-2020)
  • 2.2 Global Pneumococcal Conjugate Vaccine(PCV) Revenue Share by Manufacturers (2015-2020)
  • 2.3 Global Pneumococcal Conjugate Vaccine(PCV) Average Price by Manufacturers (2015-2020)
  • 2.4 Manufacturers Pneumococcal Conjugate Vaccine(PCV) Manufacturing Sites, Area Served, Product Type
  • 2.5 Pneumococcal Conjugate Vaccine(PCV) Market Competitive Situation and Trends
    • 2.5.1 Pneumococcal Conjugate Vaccine(PCV) Market Concentration Rate
    • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
    • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 2.7 Primary Interviews with Key Pneumococcal Conjugate Vaccine(PCV) Players (Opinion Leaders)

3 Pneumococcal Conjugate Vaccine(PCV) Retrospective Market Scenario by Region

  • 3.1 Global Pneumococcal Conjugate Vaccine(PCV) Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global Pneumococcal Conjugate Vaccine(PCV) Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America Pneumococcal Conjugate Vaccine(PCV) Market Facts & Figures by Country
    • 3.3.1 North America Pneumococcal Conjugate Vaccine(PCV) Sales by Country
    • 3.3.2 North America Pneumococcal Conjugate Vaccine(PCV) Sales by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Pneumococcal Conjugate Vaccine(PCV) Market Facts & Figures by Country
    • 3.4.1 Europe Pneumococcal Conjugate Vaccine(PCV) Sales by Country
    • 3.4.2 Europe Pneumococcal Conjugate Vaccine(PCV) Sales by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales by Region
    • 3.5.2 Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Sales by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Pneumococcal Conjugate Vaccine(PCV) Market Facts & Figures by Country
    • 3.6.1 Latin America Pneumococcal Conjugate Vaccine(PCV) Sales by Country
    • 3.6.2 Latin America Pneumococcal Conjugate Vaccine(PCV) Sales by Country
    • 3.6.3 Mexico
    • 3.6.3 Brazil
    • 3.6.3 Argentina
  • 3.7 Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Sales by Country
    • 3.7.2 Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Sales by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Pneumococcal Conjugate Vaccine(PCV) Historic Market Analysis by Type

  • 4.1 Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Type (2015-2020)
  • 4.2 Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Type (2015-2020)
  • 4.3 Global Pneumococcal Conjugate Vaccine(PCV) Price Market Share by Type (2015-2020)
  • 4.4 Global Pneumococcal Conjugate Vaccine(PCV) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Pneumococcal Conjugate Vaccine(PCV) Historic Market Analysis by Application

  • 5.1 Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Application (2015-2020)
  • 5.2 Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Application (2015-2020)
  • 5.3 Global Pneumococcal Conjugate Vaccine(PCV) Price by Application (2015-2020)

6 Company Profiles and Key Figures in Pneumococcal Conjugate Vaccine(PCV) Business

  • 6.1 Pfizer
    • 6.1.1 Corporation Information
    • 6.1.2 Pfizer Description, Business Overview and Total Revenue
    • 6.1.3 Pfizer Pneumococcal Conjugate Vaccine(PCV) Sales, Revenue and Gross Margin (2015-2020)
    • 6.1.4 Pfizer Products Offered
    • 6.1.5 Pfizer Recent Development
  • 6.2 GSK
    • 6.2.1 GSK Pneumococcal Conjugate Vaccine(PCV) Production Sites and Area Served
    • 6.2.2 GSK Description, Business Overview and Total Revenue
    • 6.2.3 GSK Pneumococcal Conjugate Vaccine(PCV) Sales, Revenue and Gross Margin (2015-2020)
    • 6.2.4 GSK Products Offered
    • 6.2.5 GSK Recent Development
  • 6.3 Sanofi
    • 6.3.1 Sanofi Pneumococcal Conjugate Vaccine(PCV) Production Sites and Area Served
    • 6.3.2 Sanofi Description, Business Overview and Total Revenue
    • 6.3.3 Sanofi Pneumococcal Conjugate Vaccine(PCV) Sales, Revenue and Gross Margin (2015-2020)
    • 6.3.4 Sanofi Products Offered
    • 6.3.5 Sanofi Recent Development
  • 6.4 Merck
    • 6.4.1 Merck Pneumococcal Conjugate Vaccine(PCV) Production Sites and Area Served
    • 6.4.2 Merck Description, Business Overview and Total Revenue
    • 6.4.3 Merck Pneumococcal Conjugate Vaccine(PCV) Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Merck Products Offered
    • 6.4.5 Merck Recent Development
  • 6.5 Walvax Biotechnology
    • 6.5.1 Walvax Biotechnology Pneumococcal Conjugate Vaccine(PCV) Production Sites and Area Served
    • 6.5.2 Walvax Biotechnology Description, Business Overview and Total Revenue
    • 6.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine(PCV) Sales, Revenue and Gross Margin (2015-2020)
    • 6.5.4 Walvax Biotechnology Products Offered
    • 6.5.5 Walvax Biotechnology Recent Development
  • 6.6 Royal (Wuxi) Bio-Pharmaceutical
    • 6.6.1 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine(PCV) Production Sites and Area Served
    • 6.6.2 Royal (Wuxi) Bio-Pharmaceutical Description, Business Overview and Total Revenue
    • 6.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine(PCV) Sales, Revenue and Gross Margin (2015-2020)
    • 6.6.4 Royal (Wuxi) Bio-Pharmaceutical Products Offered
    • 6.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development
  • 6.7 Zhifei Biologic
    • 6.6.1 Zhifei Biologic Pneumococcal Conjugate Vaccine(PCV) Production Sites and Area Served
    • 6.6.2 Zhifei Biologic Description, Business Overview and Total Revenue
    • 6.6.3 Zhifei Biologic Pneumococcal Conjugate Vaccine(PCV) Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Zhifei Biologic Products Offered
    • 6.7.5 Zhifei Biologic Recent Development

7 Pneumococcal Conjugate Vaccine(PCV) Manufacturing Cost Analysis

  • 7.1 Pneumococcal Conjugate Vaccine(PCV) Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Raw Materials Price Trend
    • 7.1.3 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Pneumococcal Conjugate Vaccine(PCV)
  • 7.4 Pneumococcal Conjugate Vaccine(PCV) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Pneumococcal Conjugate Vaccine(PCV) Distributors List
  • 8.3 Pneumococcal Conjugate Vaccine(PCV) Customers

9 Market Dynamics

  • 9.1 Market Trends
  • 9.2 Opportunities and Drivers
  • 9.3 Challenges
  • 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

  • 10.1 Global Pneumococcal Conjugate Vaccine(PCV) Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Pneumococcal Conjugate Vaccine(PCV) by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of Pneumococcal Conjugate Vaccine(PCV) by Type (2021-2026)
  • 10.2 Pneumococcal Conjugate Vaccine(PCV) Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Pneumococcal Conjugate Vaccine(PCV) by Application (2021-2026)
    • 10.2.2 Global Forecasted Revenue of Pneumococcal Conjugate Vaccine(PCV) by Application (2021-2026)
  • 10.3 Pneumococcal Conjugate Vaccine(PCV) Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Pneumococcal Conjugate Vaccine(PCV) by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of Pneumococcal Conjugate Vaccine(PCV) by Region (2021-2026)
  • 10.4 North America Pneumococcal Conjugate Vaccine(PCV) Estimates and Projections (2021-2026)
  • 10.5 Europe Pneumococcal Conjugate Vaccine(PCV) Estimates and Projections (2021-2026)
  • 10.6 Asia Pacific Pneumococcal Conjugate Vaccine(PCV) Estimates and Projections (2021-2026)
  • 10.7 Latin America Pneumococcal Conjugate Vaccine(PCV) Estimates and Projections (2021-2026)
  • 10.8 Middle East and Africa Pneumococcal Conjugate Vaccine(PCV) Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The global Pneumococcal Conjugate Vaccine(PCV) market is valued at US$ xx million in 2019 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
    This report focuses on Pneumococcal Conjugate Vaccine(PCV) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pneumococcal Conjugate Vaccine(PCV) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

    Market Segment Analysis
    The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type, the Pneumococcal Conjugate Vaccine(PCV) market is segmented into
    Tetravalent Vaccine
    8-valent Vaccine
    11-valent Vaccine
    13-valent Vaccine

    Segment by Application
    Children
    Adult

    Global Pneumococcal Conjugate Vaccine(PCV) Market: Regional Analysis
    The Pneumococcal Conjugate Vaccine(PCV) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
    The key regions covered in the Pneumococcal Conjugate Vaccine(PCV) market report are:
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    Global Pneumococcal Conjugate Vaccine(PCV) Market: Competitive Analysis
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

    The major players in global Pneumococcal Conjugate Vaccine(PCV) market include:
    Pfizer
    GSK
    Sanofi
    Merck
    Walvax Biotechnology
    Royal (Wuxi) Bio-Pharmaceutical

    Buy now